Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inborn errors of immunity in children with neuroinflammation.

Developmental medicine and child neurology·2026
Same author

A Retrospective Cohort Study of Nutrition Outcomes in Children With Spinal Muscular Atrophy Type 1 and 2 Treated With Disease Modifying Therapies.

Muscle & nerve·2026
Same author

Lingual Dyskinesia as the Presenting Feature of Acquired Demyelinating Syndrome: A Case Report and Review of Differential Diagnoses.

Journal of paediatrics and child health·2026
Same author

Charcot-Marie-Tooth disease and related neuropathies.

Nature reviews. Disease primers·2026
Same author

Bilateral frontal periventricular nodular heterotopia: a distinctive cortical malformation.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025
Same author

Sleep and Fatigue in Children and Adolescents With Multiple Sclerosis.

Journal of child neurology·2025

Related Experiment Video

Updated: Jun 28, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

Duchenne muscular dystrophy.

Eppie M Yiu1, Andrew J Kornberg

  • 1Children's Neuroscience Centre, Royal Children's Hospital Melbourne, Australia.

Neurology India
|November 1, 2008
PubMed
Summary
This summary is machine-generated.

Duchenne muscular dystrophy (DMD) is a common childhood X-linked disorder causing progressive muscle weakness. While current treatments improve quality of life, research continues for a cure for this severe condition.

More Related Videos

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Area of Science:

  • Genetics and Molecular Biology
  • Pediatric Neurology
  • Rare Diseases

Background:

  • Duchenne muscular dystrophy (DMD) is the most prevalent childhood X-linked muscular dystrophy.
  • Characterized by proximal muscle weakness and calf hypertrophy, DMD typically leads to wheelchair dependence by age 12.
  • Cardiorespiratory complications are the primary cause of mortality, usually in the late teens to early twenties.

Purpose of the Study:

  • To review the clinical features, diagnostic investigations, and current management strategies for Duchenne muscular dystrophy.
  • To provide an overview of recent advancements and novel therapeutic approaches for DMD.
  • To highlight the ongoing efforts towards finding a definitive cure for this debilitating genetic disorder.

Main Methods:

  • Literature review of clinical features, investigations, and management of DMD.
  • Analysis of current treatment modalities, including corticosteroids and respiratory support.
  • Exploration of emerging novel therapies and research directions for Duchenne muscular dystrophy.

Main Results:

  • Current management, including corticosteroids and ventilation, has improved function, ambulation, quality of life, and life expectancy in DMD patients.
  • Despite advances, DMD remains a devastating disorder with significant morbidity and mortality.
  • Novel therapies are under investigation with the aim of providing a cure for Duchenne muscular dystrophy.

Conclusions:

  • Duchenne muscular dystrophy requires comprehensive management focusing on symptom control and supportive care.
  • Ongoing research into novel therapies offers hope for more effective treatments and potential cures.
  • Continued investigation into the pathophysiology and therapeutic targets of DMD is crucial for improving patient outcomes.